CLL (Chronic Lymphocytic Leukemia),DLBCL (Diffuse Large B Cell Lymphoma),Leukemia,Lymphoma Rapcabtagene Autoleucel Shows Durable Efficacy And Manageable Safety In R/R DLBCL Patients Nov 08, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Pirtobrutinib Shows Long‑Term Safety In Relapsed/Refractory B‑Cell Malignancies Nov 08, 2023
ALL (Acute Lymphoblastic Leukemia),Leukemia Assessing The Impact Of Allogeneic Stem Cell Transplantation In Ph-Like Patients Nov 08, 2023
ALL (Acute Lymphoblastic Leukemia),Leukemia Allo-HCT For ETP And Near-ETP ALL/LBL In Remission Nov 07, 2023
AML (Acute Myeloid Leukemia),Leukemia FLT3‑ITD– Specific MRD Clearance Improves OS In FLT3-ITD+ AML Patients Nov 06, 2023
AML (Acute Myeloid Leukemia),Leukemia Quizartinib Extends OS In FLT3-ITD + AML Irrespective Of Allo-HCT In CR1 Oct 17, 2023
